Cargando…

Cell Signaling-Based Classifier Predicts Response to Induction Therapy in Elderly Patients with Acute Myeloid Leukemia

Single-cell network profiling (SCNP) data generated from multi-parametric flow cytometry analysis of bone marrow (BM) and peripheral blood (PB) samples collected from patients >55 years old with non-M3 AML were used to train and validate a diagnostic classifier (DX(SCNP)) for predicting response...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cesano, Alessandra, Willman, Cheryl L., Kopecky, Kenneth J., Gayko, Urte, Putta, Santosh, Louie, Brent, Westfall, Matt, Purvis, Norman, Spellmeyer, David C., Marimpietri, Carol, Cohen, Aileen C., Hackett, James, Shi, Jing, Walker, Michael G., Sun, Zhuoxin, Paietta, Elisabeth, Tallman, Martin S., Cripe, Larry D., Atwater, Susan, Appelbaum, Frederick R., Radich, Jerald P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4401549/ https://www.ncbi.nlm.nih.gov/pubmed/25884949 http://dx.doi.org/10.1371/journal.pone.0118485

Ejemplares similares

Functional Pathway Analysis Using SCNP of FLT3 Receptor Pathway Deregulation in AML Provides Prognostic Information Independent from Mutational Status
por: Cesano, Alessandra, et al.
Publicado: (2013)

Functional Characterization of FLT3 Receptor Signaling Deregulation in Acute Myeloid Leukemia by Single Cell Network Profiling (SCNP)
por: Rosen, David B., et al.
Publicado: (2010)

Signaling changes in the stem cell factor–AKT-S6 pathway in diagnostic AML samples are associated with disease relapse
por: Kornblau, S M, et al.
Publicado: (2011)

High-dimensional analysis of the aging immune system: Verification of age-associated differences in immune signaling responses in healthy donors
por: Longo, Diane M, et al.
Publicado: (2014)

Solving the Mystery of Myelodysplasia
por: Radich, Jerald
Publicado: (2008)

The Prognostic Significance of IRF8 Transcripts in Adult Patients with Acute Myeloid Leukemia
por: Pogosova-Agadjanyan, Era L., et al.
Publicado: (2013)

Another Philadelphia story*
por: Radich, Jerald P.
Publicado: (2022)

Association of immunophenotype with expression of topoisomerase II α and β in adult acute myeloid leukemia
por: Michelson, Andrew P., et al.
Publicado: (2020)

CNS involvement in AML at diagnosis is rare and does not affect response or survival: data from 11 ECOG-ACRIN trials
por: Ganzel, Chezi, et al.
Publicado: (2021)

Impact of Minimal Residual Disease, Detected by Flow Cytometry, on Outcome of Myeloablative Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia
por: Bar, Merav, et al.
Publicado: (2014)

Examining the impact of age on the prognostic value of ELN-2017 and ELN-2022 acute myeloid leukemia risk stratifications: a report from the SWOG Cancer Research Network
por: Termini, Christina M., et al.
Publicado: (2023)

From molecular interaction to acute promyelocytic leukemia: Calculating leukemogenesis and remission from endogenous molecular-cellular network
por: Yuan, Ruoshi, et al.
Publicado: (2016)

CML Outcomes and Care Delivery During the COVID-19 Pandemic in Low- and Middle-Income Countries
por: Matsuzaki, Mika, et al.
Publicado: (2023)

Integrative analysis identifies an older female-linked AML patient group with better risk in ECOG-ACRIN Cancer Research Group’s clinical trial E3999
por: Rapaport, Franck, et al.
Publicado: (2022)

Correction: Integrative analysis identifies an older female-linked AML patient group with better risk in ECOG-ACRIN Cancer Research Group’s clinical trial E3999
por: Rapaport, Franck, et al.
Publicado: (2023)

Distinct Patterns of DNA Damage Response and Apoptosis Correlate with Jak/Stat and PI3Kinase Response Profiles in Human Acute Myelogenous Leukemia
por: Rosen, David B., et al.
Publicado: (2010)

Pre- and Post-Transplant Quantification of Measurable (“Minimal”) Residual Disease via Multiparameter Flow Cytometry in Adult Acute Myeloid Leukemia
por: Zhou, Yi, et al.
Publicado: (2016)

Comparison of Two Methods for Detecting Alternative Splice Variants Using GeneChip(®) Exon Arrays
por: Fan, Wenhong, et al.
Publicado: (2011)

Spectrum of BCR-ABL Mutations and Treatment Outcomes in Ethiopian Imatinib-Resistant Patients With Chronic Myeloid Leukemia
por: Tadesse, Fisihatsion, et al.
Publicado: (2021)

AML risk stratification models utilizing ELN-2017 guidelines and additional prognostic factors: a SWOG report
por: Pogosova-Agadjanyan, Era L., et al.
Publicado: (2020)

Ultrasensitive chimerism enhances measurable residual disease testing after allogeneic hematopoietic cell transplantation
por: Kanaan, Sami B., et al.
Publicado: (2023)

Book Review: “Classifying Reality,” by David S. Oderberg (ed.) (2013)
por: Hackett, Paul M. W.
Publicado: (2015)

Effect of Genetic Profiling on Prediction of Therapeutic Resistance and Survival in Adult Acute Myeloid Leukemia
por: Walter, Roland B., et al.
Publicado: (2015)

Molecular alterations of the IDH1 gene in AML: a Children’s Oncology Group and Southwest Oncology Group study
por: Ho, Phoenix A., et al.
Publicado: (2010)

Verification of prognostic expression biomarkers is improved by examining enriched leukemic blasts rather than mononuclear cells from acute myeloid leukemia patients
por: Pogosova-Agadjanyan, Era L., et al.
Publicado: (2023)

Characteristics and prognostic impact of IDH mutations in AML: a COG, SWOG, and ECOG analysis
por: Zarnegar-Lumley, Sara, et al.
Publicado: (2023)

Targeted detection and quantitation of histone modifications from 1,000 cells
por: Abshiru, Nebiyu A., et al.
Publicado: (2020)

TTMV-RARA fusion as a recurrent cause of AML with APL characteristics
por: Sala-Torra, Olga, et al.
Publicado: (2022)

Dying From Cancer: Communication, Empathy, and the Clinical Imagination
por: Cripe, Larry D, et al.
Publicado: (2017)

An evolutionary explanation for the presence of cancer nonstem cells in neoplasms
por: Sprouffske, Kathleen, et al.
Publicado: (2013)

Self-Digitization Microfluidic Chip for Absolute Quantification of mRNA in Single Cells
por: Thompson, Alison M., et al.
Publicado: (2014)

Analysis of the gap in PCR monitoring availability for patients with chronic myeloid leukemia in 60 low- and middle-income countries
por: Rowley, Seth, et al.
Publicado: (2021)

Systems biology analysis of immune signaling in peripheral blood mononuclear cells (PBMC) of melanoma patients receiving ipilimumab; basis for clinical response biomarker identification
por: Hotson, Drew, et al.
Publicado: (2013)

Effectiveness and Cost-Effectiveness of Sequential Treatment of Patients with Chronic Myeloid Leukemia in the United States: A Decision Analysis
por: Rochau, Ursula, et al.
Publicado: (2015)

A graphical, interactive and GPU-enabled workflow to process long-read sequencing data
por: Reddy, Shishir, et al.
Publicado: (2021)

Performance characteristics of the first Food and Drug Administration (FDA)-cleared digital droplet PCR (ddPCR) assay for BCR::ABL1 monitoring in chronic myelogenous leukemia
por: Shelton, Dawne N., et al.
Publicado: (2022)

AKT Signaling as a Novel Factor Associated with In Vitro Resistance of Human AML to Gemtuzumab Ozogamicin
por: Rosen, David B., et al.
Publicado: (2013)

Interrogating the molecular genetics of chronic myeloproliferative malignancies for personalized management in 2021
por: Mughal, Tariq I., et al.
Publicado: (2021)

Management of chronic myeloid leukemia in 2023 – common ground and common sense
por: Senapati, Jayastu, et al.
Publicado: (2023)

Classifying spaces and classifying topoi
por: Moerdijk, Izak
Publicado: (1995)

Cannot write session to /tmp/vufind_sessions/sess_3s9jefeepum8ul0o3n522k9okf